Member Info for dafad

4 pm uk time

https://www.techradar.com/audio/earbuds-airpods/sonys-new-wf-1000xm6-elite-earbuds-seem-to-be-imminent-here-are-3-upgrades-i-hope-to-see-as-a-headphones-reviewer

Market Maker Signal (900): In Level 2 market data, code 900 indicates that market makers are allowing a stock's price to float naturally, often following a period of managed trading (like accumulation or stabilization

Mka on the nove aswelk-could funding USnews be near on several co's

Did they pay over the odds for this tenament to help them with the access road-knowing full well what they have at Red Setter??

They may have wanted someone of a higher calibre in the position as they develop the Platform

Full rns

https://www.londonstockexchange.com/news-article/REE/us-government-confirms-support-for-monte-muambe/17451260

Interesting paragraph

This commitment from USTDA coincides with a broader announcement by the United States Government at the 2026 Critical Minerals Ministerial. The announcement outlined a tangible commitment to reshape the global critical minerals market through the Forum on Resource Geostrategic Engagement (FORGE), alongside the mobilisation of significant and unprecedented resources to secure resilient and sustainable mineral supply chains.

Interesting article

https://rareearthexchanges.com/news/the-robots-arrive-carrying-magnets/

Https://investornews.com/market-opinion/follow-the-money-u-s-government-funding-for-critical-minerals-companies-2023-2026/

Interesting

https://www.wam.ae/en/article/1726dev-uae-sign-framework-securing-supply-critical

Mmm!!????

And working towards the Company's intention to pursue a U.S. public listing.

Together these developments reflect accelerating momentum as HyProMag USA advances toward commercial operations and a scaled manufacturing footprint across the U.S.Across the j

Https://www.londonstockexchange.com/news-article/MKA/hypromag-usa-advances-u-s-hub-and-spoke-strategy/17447258

From year end update

In addition, the Company expects to release data in the TNBC cohort in H1 2026. Further development of faridoxorubicin will be undertaken subject to a partner being secured

So tell me how long other cancer treatments take to come to market on average.Tia

That is the key word here!@

Furthermore, identifying the path forward to the selection of the optimal biologic dose will enable a smooth transition to efficacy studies with faridoxorubicin program and allows the Company to implement these approaches in the platform currently in Phase 1b, facilitating the development across pre|CISION® medicines."

Pick the holes from that Bashers@

Https://x.com/EximBankUS/status/2018406982357483675/mediaViewer?currentTweet=2018406982357483675¤tTweetUser=EximBankUS

Https://www.theguardian.com/world/2026/feb/02/damning-eu-report-lays-bare-blocs-dangerous-dependence-on-critical-mineral-imports